A citation-based method for searching scientific literature

Xiao-Jing Zhang, Peng Zhang, Hongliang Li. Hypertension 2015
Times Cited: 41







List of co-cited articles
457 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The ubiquitin E3 ligase TRAF6 exacerbates pathological cardiac hypertrophy via TAK1-dependent signalling.
Yan-Xiao Ji, Peng Zhang, Xiao-Jing Zhang, Yi-Chao Zhao, Ke-Qiong Deng, Xi Jiang, Pi-Xiao Wang, Zan Huang, Hongliang Li. Nat Commun 2016
120
36

Interferon regulatory factor 3 constrains IKKβ/NF-κB signaling to alleviate hepatic steatosis and insulin resistance.
Xin-An Wang, Ran Zhang, Zhi-Gang She, Xiao-Fei Zhang, Ding-Sheng Jiang, Tao Wang, Lu Gao, Wei Deng, Shu-Min Zhang, Li-Hua Zhu,[...]. Hepatology 2014
108
29

IRF8 suppresses pathological cardiac remodelling by inhibiting calcineurin signalling.
Ding-Sheng Jiang, Xiang Wei, Xiao-Fei Zhang, Yu Liu, Yan Zhang, Ke Chen, Lu Gao, Heng Zhou, Xue-Hai Zhu, Peter P Liu,[...]. Nat Commun 2014
112
29

Interferon regulatory factor 9 protects against cardiac hypertrophy by targeting myocardin.
Ding-Sheng Jiang, Yu-Xuan Luo, Ran Zhang, Xiao-Dong Zhang, Hou-Zao Chen, Yan Zhang, Ke Chen, Shu-Min Zhang, Guo-Chang Fan, Peter P Liu,[...]. Hypertension 2014
64
26

Hepatocyte TRAF3 promotes liver steatosis and systemic insulin resistance through targeting TAK1-dependent signalling.
Pi-Xiao Wang, Xiao-Jing Zhang, Pengcheng Luo, Xi Jiang, Peng Zhang, Junhong Guo, Guang-Nian Zhao, Xueyong Zhu, Yan Zhang, Sijun Yang,[...]. Nat Commun 2016
95
26

Interferon regulatory factor 7 functions as a novel negative regulator of pathological cardiac hypertrophy.
Ding-Sheng Jiang, Yu Liu, Heng Zhou, Yan Zhang, Xiao-Dong Zhang, Xiao-Fei Zhang, Ke Chen, Lu Gao, Juan Peng, Hui Gong,[...]. Hypertension 2014
62
24

Role of interferon regulatory factor 4 in the regulation of pathological cardiac hypertrophy.
Ding-Sheng Jiang, Zhou-Yan Bian, Yan Zhang, Shu-Min Zhang, Yi Liu, Rui Zhang, Yingjie Chen, Qinglin Yang, Xiao-Dong Zhang, Guo-Chang Fan,[...]. Hypertension 2013
79
24

Interferon regulatory factor 3 is a negative regulator of pathological cardiac hypertrophy.
Jing Lu, Zhou-Yan Bian, Ran Zhang, Yan Zhang, Chen Liu, Ling Yan, Shu-Min Zhang, Ding-Sheng Jiang, Xiang Wei, Xue Hai Zhu,[...]. Basic Res Cardiol 2013
62
24

Interferon regulatory factor 9 protects against hepatic insulin resistance and steatosis in male mice.
Xin-An Wang, Ran Zhang, Dingsheng Jiang, Wei Deng, Shumin Zhang, Shan Deng, Jinfeng Zhong, Tao Wang, Li-Hua Zhu, Li Yang,[...]. Hepatology 2013
64
24

Suppressor of IKKɛ is an essential negative regulator of pathological cardiac hypertrophy.
Ke-Qiong Deng, Aibing Wang, Yan-Xiao Ji, Xiao-Jing Zhang, Jing Fang, Yan Zhang, Peng Zhang, Xi Jiang, Lu Gao, Xue-Yong Zhu,[...]. Nat Commun 2016
54
24

Interferon regulatory factor 1 is required for cardiac remodeling in response to pressure overload.
Ding-Sheng Jiang, Liangpeng Li, Ling Huang, Jun Gong, Hao Xia, Xiaoxiong Liu, Nian Wan, Xiang Wei, Xuehai Zhu, Yingjie Chen,[...]. Hypertension 2014
58
21

Interferon regulatory factor 9 is critical for neointima formation following vascular injury.
Shu-Min Zhang, Li-Hua Zhu, Hou-Zao Chen, Ran Zhang, Peng Zhang, Ding-Sheng Jiang, Lu Gao, Song Tian, Lang Wang, Yan Zhang,[...]. Nat Commun 2014
53
21

Reprogramming Interferon Regulatory Factor Signaling in Cardiometabolic Diseases.
Yaxing Zhang, Hongliang Li. Physiology (Bethesda) 2017
22
40

Reprogramming Innate Immune Signaling in Cardiometabolic Disease.
Yaxing Zhang, Xiao-Jing Zhang, Pi-Xiao Wang, Peng Zhang, Hongliang Li. Hypertension 2017
19
47

Signal regulatory protein-α protects against cardiac hypertrophy via the disruption of toll-like receptor 4 signaling.
Ding-Sheng Jiang, Xiao-Fei Zhang, Lu Gao, Jing Zong, Heng Zhou, Yu Liu, Yan Zhang, Zhou-Yan Bian, Li-Hua Zhu, Guo-Chang Fan,[...]. Hypertension 2014
51
19

Interferon regulatory factor 9 is a key mediator of hepatic ischemia/reperfusion injury.
Pi-Xiao Wang, Ran Zhang, Ling Huang, Li-Hua Zhu, Ding-Sheng Jiang, Hou-Zao Chen, Yan Zhang, Song Tian, Xiao-Fei Zhang, Xiao-Dong Zhang,[...]. J Hepatol 2015
58
19

Interferon regulatory factor 7 deficiency prevents diet-induced obesity and insulin resistance.
Xin-An Wang, Ran Zhang, Shumin Zhang, Shan Deng, Dingsheng Jiang, Jinfeng Zhong, Li Yang, Tao Wang, Shufen Hong, Sen Guo,[...]. Am J Physiol Endocrinol Metab 2013
69
19

Targeting hepatic TRAF1-ASK1 signaling to improve inflammation, insulin resistance, and hepatic steatosis.
Mei Xiang, Pi-Xiao Wang, Ai-Bing Wang, Xiao-Jing Zhang, Yaxing Zhang, Peng Zhang, Fang-Hua Mei, Man-Hua Chen, Hongliang Li. J Hepatol 2016
99
19

Tumor necrosis factor receptor-associated factor 5 (Traf5) acts as an essential negative regulator of hepatic steatosis.
Ling Gao, Pi-Xiao Wang, Yaxing Zhang, Chang-Jiang Yu, Yanxiao Ji, Xiaozhan Wang, Peng Zhang, Xi Jiang, Hong Jin, Zan Huang,[...]. J Hepatol 2016
36
22

Interferon regulatory factor 9 is an essential mediator of heart dysfunction and cell death following myocardial ischemia/reperfusion injury.
Yan Zhang, Xiaoxiong Liu, Zhi-Gang She, Ding-Sheng Jiang, Nian Wan, Hao Xia, Xue-Hai Zhu, Xiang Wei, Xiao-Dong Zhang, Hongliang Li. Basic Res Cardiol 2014
43
17

Interferon regulatory factor 7 protects against vascular smooth muscle cell proliferation and neointima formation.
Ling Huang, Shu-Min Zhang, Peng Zhang, Xiao-Jing Zhang, Li-Hua Zhu, Ke Chen, Lu Gao, Yan Zhang, Xiang-Jie Kong, Song Tian,[...]. J Am Heart Assoc 2014
26
26

Regulation of cardiac hypertrophy by intracellular signalling pathways.
Joerg Heineke, Jeffery D Molkentin. Nat Rev Mol Cell Biol 2006
17

Interferon regulatory factor 3 protects against adverse neo-intima formation.
Shu-Min Zhang, Li-Hua Zhu, Zuo-Zhi Li, Pi-Xiao Wang, Hou-Zao Chen, Hong-Jing Guan, Ding-Sheng Jiang, Ke Chen, Xiao-Fei Zhang, Song Tian,[...]. Cardiovasc Res 2014
20
35

Interferon regulatory factor 8 modulates phenotypic switching of smooth muscle cells by regulating the activity of myocardin.
Shu-Min Zhang, Lu Gao, Xiao-Fei Zhang, Ran Zhang, Li-Hua Zhu, Pi-Xiao Wang, Song Tian, Da Yang, Ke Chen, Ling Huang,[...]. Mol Cell Biol 2014
31
22

Interferon regulatory factors: at the crossroads of immunity, metabolism, and disease.
Guang-Nian Zhao, Ding-Sheng Jiang, Hongliang Li. Biochim Biophys Acta 2015
132
17

The innate immune signaling in cancer and cardiometabolic diseases: Friends or foes?
Weijun Wang, Yaxing Zhang, Ling Yang, Hongliang Li. Cancer Lett 2017
15
46

Liver capsule: IRFs in hepatocytes: Pathophysiology.
Pi-Xiao Wang, Xiao-Jing Zhang, Hongliang Li. Hepatology 2016
10
70

Tmbim1 is a multivesicular body regulator that protects against non-alcoholic fatty liver disease in mice and monkeys by targeting the lysosomal degradation of Tlr4.
Guang-Nian Zhao, Peng Zhang, Jun Gong, Xiao-Jing Zhang, Pi-Xiao Wang, Miao Yin, Zhou Jiang, Li-Jun Shen, Yan-Xiao Ji, Jingjing Tong,[...]. Nat Med 2017
93
17

Irf5 deficiency in macrophages promotes beneficial adipose tissue expansion and insulin sensitivity during obesity.
Elise Dalmas, Amine Toubal, Fawaz Alzaid, Katrina Blazek, Hayley L Eames, Kristell Lebozec, Maria Pini, Isabelle Hainault, Emilie Montastier, Raphaël G P Denis,[...]. Nat Med 2015
125
14

Disruption of tumor necrosis factor receptor associated factor 5 exacerbates pressure overload cardiac hypertrophy and fibrosis.
Zhouyan Bian, Jia Dai, Nakano Hiroyasu, Hongjing Guan, Yuan Yuan, Lihua Gan, Heng Zhou, Jing Zong, Yan Zhang, Fangfang Li,[...]. J Cell Biochem 2014
23
26

A central role of interferon regulatory factor-1 for the limitation of neointimal hyperplasia.
Rainer Wessely, Ludger Hengst, Birgit Jaschke, Franziska Wegener, Thomas Richter, Raffaella Lupetti, Makarios Paschalidis, Albert Schömig, Richard Brandl, Franz-Josef Neumann. Hum Mol Genet 2003
40
15


Mindin/Spondin 2 inhibits hepatic steatosis, insulin resistance, and obesity via interaction with peroxisome proliferator-activated receptor α in mice.
Li-Hua Zhu, Aibing Wang, Pengcheng Luo, Xinan Wang, Ding-Sheng Jiang, Wei Deng, Xiaofei Zhang, Tao Wang, Yi Liu, Lu Gao,[...]. J Hepatol 2014
41
14

The IRF family transcription factors in immunity and oncogenesis.
Tomohiko Tamura, Hideyuki Yanai, David Savitsky, Tadatsugu Taniguchi. Annu Rev Immunol 2008
868
14

IRF4 is a novel mediator for neuronal survival in ischaemic stroke.
S Guo, Z-Z Li, D-S Jiang, Y Y Lu, Y Liu, L Gao, S-M Zhang, H Lei, L-H Zhu, X-D Zhang,[...]. Cell Death Differ 2014
46
14

IRF4 is a key thermogenic transcriptional partner of PGC-1α.
Xingxing Kong, Alexander Banks, Tiemin Liu, Lawrence Kazak, Rajesh R Rao, Paul Cohen, Xun Wang, Songtao Yu, James C Lo, Yu-Hua Tseng,[...]. Cell 2014
179
14

Interferon regulatory factor 4 regulates obesity-induced inflammation through regulation of adipose tissue macrophage polarization.
Jun Eguchi, Xingxing Kong, Masafumi Tenta, Xun Wang, Sona Kang, Evan D Rosen. Diabetes 2013
85
14

Innate immune pattern recognition: a cell biological perspective.
Sky W Brubaker, Kevin S Bonham, Ivan Zanoni, Jonathan C Kagan. Annu Rev Immunol 2015
821
14

Hepatic Oncostatin M Receptor β Regulates Obesity-Induced Steatosis and Insulin Resistance.
Pengcheng Luo, Pi-Xiao Wang, Zuo-Zhi Li, Xiao-Jing Zhang, Xi Jiang, Jun Gong, Juan-Juan Qin, Junhong Guo, Xueyong Zhu, Sijun Yang,[...]. Am J Pathol 2016
26
23

Targeting TRAF3 signaling protects against hepatic ischemia/reperfusions injury.
Junfei Hu, Xue-Hai Zhu, Xiao-Jing Zhang, Pi-Xiao Wang, Ran Zhang, Peng Zhang, Guang-Nian Zhao, Lu Gao, Xiao-Fei Zhang, Song Tian,[...]. J Hepatol 2016
70
14

DKK3 expression in hepatocytes defines susceptibility to liver steatosis and obesity.
Lanfeng Xie, Pi-Xiao Wang, Peng Zhang, Xiao-Jing Zhang, Guang-Nian Zhao, Aibing Wang, Junhong Guo, Xueyong Zhu, Qin Zhang, Hongliang Li. J Hepatol 2016
48
14

The E3 ligase tripartite motif 8 targets TAK1 to promote insulin resistance and steatohepatitis.
Feng-Juan Yan, Xiao-Jing Zhang, Wen-Xin Wang, Yan-Xiao Ji, Pi-Xiao Wang, Yang Yang, Jun Gong, Li-Jun Shen, Xue-Yong Zhu, Zan Huang,[...]. Hepatology 2017
53
14

NOD2, RIP2 and IRF5 play a critical role in the type I interferon response to Mycobacterium tuberculosis.
Amit K Pandey, Yibin Yang, Zhaozhao Jiang, Sarah M Fortune, Francois Coulombe, Marcel A Behr, Katherine A Fitzgerald, Christopher M Sassetti, Michelle A Kelliher. PLoS Pathog 2009
201
12

Hepatic TRAF2 regulates glucose metabolism through enhancing glucagon responses.
Zheng Chen, Liang Sheng, Hong Shen, Yujun Zhao, Shaomeng Wang, Robert Brink, Liangyou Rui. Diabetes 2012
42
12

Tumor necrosis factor receptor-associated factor 5 is an essential mediator of ischemic brain infarction.
Lang Wang, Yanyun Lu, Hongjing Guan, Dingsheng Jiang, Yu Guan, Xin Zhang, Hiroyasu Nakano, Yan Zhou, Yan Zhang, Li Yang,[...]. J Neurochem 2013
35
14

Reduced cardiac hypertrophy in toll-like receptor 4-deficient mice following pressure overload.
Tuanzhu Ha, Yuehua Li, Fang Hua, Jinag Ma, Xiang Gao, Jim Kelley, Aiqiu Zhao, Georges E Haddad, David L Williams, I William Browder,[...]. Cardiovasc Res 2005
120
12

CARD3 deficiency exacerbates diet-induced obesity, hepatosteatosis, and insulin resistance in male mice.
Xin-An Wang, Shan Deng, Dingsheng Jiang, Ran Zhang, Shumin Zhang, Jinfeng Zhong, Li Yang, Tao Wang, Shufen Hong, Sen Guo,[...]. Endocrinology 2013
21
23

Transcriptional control of adipose lipid handling by IRF4.
Jun Eguchi, Xun Wang, Songtao Yu, Erin E Kershaw, Patricia C Chiu, Joanne Dushay, Jennifer L Estall, Ulf Klein, Eleftheria Maratos-Flier, Evan D Rosen. Cell Metab 2011
392
12

Signaling effectors underlying pathologic growth and remodeling of the heart.
Jop H van Berlo, Marjorie Maillet, Jeffery D Molkentin. J Clin Invest 2013
310
12

Tumor necrosis factor receptor-associated factor 3 is a positive regulator of pathological cardiac hypertrophy.
Xi Jiang, Ke-Qiong Deng, Yuxuan Luo, Ding-Sheng Jiang, Lu Gao, Xiao-Fei Zhang, Peng Zhang, Guang-Nian Zhao, Xueyong Zhu, Hongliang Li. Hypertension 2015
47
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.